We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Gore Tex Implants in the Treatment of Atrophic Rhinitis (RA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00832403
Recruitment Status : Suspended (lack of new patients)
First Posted : January 30, 2009
Last Update Posted : January 30, 2009
Sponsor:
Information provided by:
Hospital Felicio Rocho

Brief Summary:

This is a retrospective study, involving patients with atrophic rhinitis, that underwent Gore tex® implants in the nasal fossa.

The Fetid Rhinitis or Atrophic Ozena is a chronic illness characterized by yellowish secretion in the initial phase and the other phases with fetid crusts and atrophy of the mucous bone covering. Diverse theories exist that try to explain the appearance of this pathology, such as: hereditary factors, immunological alterations, viral infection and nutritional lack. Currently, its etiology remains unknown. As there isn't any ideal treatment already established, this technique improves the options of treatment.

All patients have improved after the procedure.


Condition or disease Intervention/treatment
Atrophic Rhinitis Other: implants of polytetrafluoroethylene in tha nasal fossa

Detailed Description:
Data about 5 patients that underwent surgery to implant polytetrafluoroethylene in the nasal fossa was collect. The symptoms and complications were described.

Study Type : Observational
Actual Enrollment : 5 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Gore Tex Implants in the Treatment of Atrophic Rhinitis
Study Start Date : November 2006
Primary Completion Date : February 2008

Group/Cohort Intervention/treatment
polytetrafluoroethylene Other: implants of polytetrafluoroethylene in tha nasal fossa
surgical implants of polytetrafluoroethylene in the nasal fossa



Primary Outcome Measures :
  1. improvement of fetid crusts and atrophy of the mucous bone covering [ Time Frame: after surgery recovery ]

Secondary Outcome Measures :
  1. lack of side effects such as infection [ Time Frame: after the treatment ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients that were submit to surgery to treat atrophic rhinitis with implants in the nasal fossa.
Criteria

Inclusion Criteria:

  • Symptoms of atrophic rhinitis, with previous clinical treatment without good results

Exclusion Criteria:

  • Patients with mental illness

Responsible Party: Larissa Oliveira Lauriano, Hospital Felício Rocho
ClinicalTrials.gov Identifier: NCT00832403     History of Changes
Other Study ID Numbers: Rinite Atrófica cep/hfr
First Posted: January 30, 2009    Key Record Dates
Last Update Posted: January 30, 2009
Last Verified: January 2009

Keywords provided by Hospital Felicio Rocho:
atrophic rhinitis
implants
Polytetrafluoroethylene

Additional relevant MeSH terms:
Rhinitis
Atrophy
Rhinitis, Atrophic
Nose Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Otorhinolaryngologic Diseases
Pathological Conditions, Anatomical